Prelude Therapeutics Incorporated (NASDAQ:PRLD) Q3 2025 Earnings Call Transcript
Prelude Therapeutics Incorporated (NASDAQ:PRLD) Q3 2025 Earnings Call Transcript November 12, 2025Prelude Therapeutics Incorporated beats earnings expectations.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 10,909,256 | $15,709,329 | 0.37% | |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 10,123,824 | $14,578,307 | 0.11% | |
| 3. | Millennium Management Israel Englander | 1,147,044 | $1,651,743 | +362% | 0% |
| 4. | Renaissance Technologies Jim Simons | 544,000 | $783,360 | -7% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 222,700 | $320,688 | -2% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.69 | 100,000 | $69,250.00 | 480,123 | 2025-03-25 | Filing | |
| $0.69 | 675,000 | $467,437.50 | 1,999,296 | 2025-03-25 | Filing | |
| $0.73 | 15,000 | $10,959.00 | 1,324,296 | 2025-03-21 | Filing | |
| $0.73 | 5,416 | $3,950.43 | 1,309,296 | 2025-03-20 | Filing | |
| $0.75 | 9,106 | $6,828.59 | 1,303,880 | 2025-03-17 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.12 | 13,280 | $81,273.60 | 24,220 | 2023-04-06 | Filing | |
| $13.00 | 28,751 | $373,763.00 | 444 | 2021-12-15 | Filing | |
| $16.43 | 400 | $6,570.00 | 444 | 2021-11-16 | Filing | |
| $15.87 | 28,351 | $449,961.56 | 844 | 2021-11-16 | Filing | |
| $32.06 | 1,289 | $41,330.11 | 0 | 2021-10-05 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 992,854 | $1,429,710 | 0% | |
| 2. | 284,203 | $409,252 | 0% | |
| 3. | 264,973 | $381,562 | 0% | |
| 4. | 217,568 | $313,366 | 0% | |
| 5. | 160,652 | $231,339 | 0% |